NKG2D-ACE2 CAR-NK cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NKG2D-ACE2 CAR-NK cells, covering 2020-11-17 to 2020-11-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 [Phase 1, Phase 2]